Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Dupilumab for the Treatment of Recalcitrant Bullous Pemphigoid.

Literature DB >> 30140849

Dupilumab for the Treatment of Recalcitrant Bullous Pemphigoid.

Alex Kaye¹, Samantha C Gordon¹, Sandhya C Deverapalli¹, Min Ji Her¹, David Rosmarin¹.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2018 PMID： 30140849 DOI： 10.1001/jamadermatol.2018.2526

Source DB: PubMed Journal: JAMA Dermatol ISSN： 2168-6068 Impact factor: 10.282

Keyword Cloud
Cited

× No keyword cloud information.

23 in total

1. Pipeline Perspectives and Therapy Updates.

Authors: James Q Del Rosso
Journal: J Clin Aesthet Dermatol Date: 2020-11-01

Review 2. The use of biologics for immune modulation in allergic disease.

Authors: Willem van de Veen; Mübeccel Akdis
Journal: J Clin Invest Date: 2019-03-18 Impact factor: 14.808

Review 3. Challenging Dermatologic Considerations Associated with Immune Checkpoint Inhibitors.

Authors: Benjamin C Park; Seungyeon Jung; Steven T Chen; Anna K Dewan; Douglas B Johnson
Journal: Am J Clin Dermatol Date: 2022-06-16 Impact factor: 6.233

Review 4. A Review of the Immunologic Pathways Involved in Bullous Pemphigoid and Novel Therapeutic Targets.

Authors: Mohsen Afarideh; Robert Borucki; Victoria P Werth
Journal: J Clin Med Date: 2022-05-18 Impact factor: 4.964

Review 5. Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases.

Authors: Hideyuki Ujiie; David Rosmarin; Michael P Schön; Sonja Ständer; Katharina Boch; Martin Metz; Marcus Maurer; Diamant Thaci; Enno Schmidt; Connor Cole; Kyle T Amber; Dario Didona; Michael Hertl; Andreas Recke; Hanna Graßhoff; Alexander Hackel; Anja Schumann; Gabriela Riemekasten; Katja Bieber; Gant Sprow; Joshua Dan; Detlef Zillikens; Tanya Sezin; Angela M Christiano; Kerstin Wolk; Robert Sabat; Khalaf Kridin; Victoria P Werth; Ralf J Ludwig
Journal: Front Med (Lausanne) Date: 2022-06-09

Review 6. Use of Dupilumab in Bullous Pemphigoid: Where Are We Now?

Authors: Roberto Russo; Niccolò Capurro; Emanuele Cozzani; Aurora Parodi
Journal: J Clin Med Date: 2022-06-12 Impact factor: 4.964

7. Dupilumab, an emerging therapeutic choice for recalcitrant subepidermal autoimmune bullous diseases: a case series of three patients.

Authors: Xiuting Liu; Jianchi Ma; Xiaonan Qiu; Dan Hong; Liangchun Wang; Zhenrui Shi
Journal: Eur J Dermatol Date: 2021-12-01 Impact factor: 3.328